logo
  

Honda Names Toshihiro Mibe As New CEO, Succeeding Takahiro Hachigo - Quick Facts

Japanese automaker Honda Motor Co., Ltd. (HMC) said Friday that its board of directors has named Toshihiro Mibe as the next President and Representative Director, effective April 1, 2021.

Mibe is currently the company's Senior Managing Director. He will succeed Takahiro Hachigo, the current President and Representative Director, who will become a Director, effective April 1, 2021.

Mibe is scheduled to become Director, President and Representative Executive Officer or CEO of the company with the resolution of the ordinary general meeting of shareholders to be held in June 2021, at which time Hachigo will retire from the company.

During the nearly six years since he ascended to the presidency in 2015, Hachigo took the initiative and formulated Honda's 2030 Vision to enable Honda to become "a company society wants to exist" into the future.

Mibe, who is set to assume the presidency in April, joined Honda in 1987 and has been primarily focused on the research & development of automobiles, particularly powertrain development.

In 2019, Mibe became the President and Representative Director of Honda R&D Co., Ltd., and since 2020, he has been concurrently serving as Senior Managing Director of Honda Motor Co., Ltd.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
RELATED NEWS
Follow RTT